US cardiology market price
2023
US $16.67 billion
2030
US $25.60 billion
CAGR (compound annual growth rate)
6.32%
(2024-2030)
Cardiovascular disease (CVD)
#1 reason for death in the U.S.
Market increasers
Upward growth in cardiovascular sickness due to:
- Weight problems
- High blood pressure
- Diabetes
Technology advancements
Minimally invasive methods
Imagining techniques
Material advancements
Wearables
Remote monitoring
Benefits of technology advancements
Enhance patient results
Lessen healing times
Increase efficiency of cardiovascular treatments
Technology used ranges from echocardiography machines and stress tests to catheterization labs.
Key players in the cardiovascular market
Abbott Laboratories
Boston Scientific Corp.
Edwards Lifesciences
Cardinal Health Inc.
Medtronic PLC
GE Healthcare
Johnson & Johnson Services, Inc.
Siemens Healthcare GmbH
https://www.researchandmarkets.com/report/united-states-cardiovascular-devices-market
ICONS: ADOBE STOCK
Explore the May 2024 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- IMTS 2026 runs Sept. 14-19 at McCormick Place in Chicago, Illinois
- Master Bond’s MasterSil 800Med
- ZEISS celebrates 100 years of advancing innovation in the US
- Teleflex sells acute care and urology businesses for $2.03 billion
- HANNOVER MESSE: Where research and manufacturing meet
- What’s next for the design and manufacturing industry in 2026?
- Arcline to sell Medical Manufacturing Technologies to Perimeter Solutions
- Decline in German machine tool orders bottoming out
